Author Question: After obtaining several elevated blood pressure readings from the automated sphygmomanometer in his ... (Read 26 times)

cmoore54 · **on:** Jul 23, 2018

After obtaining several elevated blood pressure readings from the automated sphygmomanometer in his local drugstore, a 51-year-old man sought care from his primary care provider.

The patient has been diagnosed with hypertension following several elevated blood pressure readings. The nurse at the clinic should recognize which of the following drug regimens as being most likely? A) Monotherapy with a loop diuretic
B) Monotherapy with an ACE inhibitor
C) A beta-blocker combined with a calcium channel blocker
D) A thiazide diuretic combined with a beta-blocker

Question 2

An obese patient has asked her nurse practitioner to prescribe sibutramine. What variable will most affect the nurse's decision?

A) Sibutramine has been taken off the market due to adverse cardiovascular effects.
B) Sibutramine is prohibitively expensive and is not covered by most insurers.
C) The use of sibutramine requires weekly blood work.
D) Sibutramine must be combined with an anticholinergic drug in order to potentiate its effects.

Silverbeard98 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

D
Feedback:
The JNC 7 guidelines suggest thiazide diuretics be used as first-line therapy, either alone (monotherapy) or with a beta-blocker, ACE inhibitor, ARB, or calcium channel blocker. Consequently, the other listed drug regimens are less likely to be implemented.

Answer to Question 2

A
Feedback:
Until recently, health care providers used sibutramine, a drug that suppresses appetite by inhibiting the reuptake of the neurotransmitters norepinephrine and serotonin, in the management of obesity. The drug is no longer available in the United States because a clinical study demonstrated an increased risk of cardiovascular events such as heart attack and stroke with its use.